BDBM281753 4-(5-Acryloyl-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-9-yl)-3-fluoro-7-(trifluoromethyl)-9H-carbazole-1-carboxamide (Single Enantiomeric Atropisomer)::US10023534, Example 12

SMILES C=CC(=O)N1CCCOc2c(-c3c(F)cc(C(N)=O)c4[nH]c5cc(C(F)(F)F)ccc5c34)cccc21

InChI Key InChIKey=BTFCQXVLYOYMKZ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 281753   

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 281753BDBM281753(4-(5-Acryloyl-2,3,4,5-tetrahydrobenzo[b][1,4]oxaze...)
Affinity DataIC50: 0.370nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent